Key facts
- Johnson & Johnson proposed a voluntary settlement.
- The proposed settlement is worth at least $5.5 billion.
- The settlement aims to resolve thousands of lawsuits.
- Lawsuits allege Johnson & Johnson's talc products caused ovarian cancer.
- The company previously attempted to use bankruptcy to settle claims.
- Previous bankruptcy attempts to settle claims were unsuccessful.
Johnson & Johnson has put forward a voluntary settlement proposal valued at a minimum of $5.5 billion. This offer is intended to resolve a significant number of lawsuits that allege the company's talc products are responsible for causing ovarian cancer. The proposed settlement represents an effort by Johnson & Johnson to address the extensive litigation it faces regarding its talc-based powders. Previously, the company attempted to use bankruptcy court as a mechanism to settle these claims, but those efforts were unsuccessful. The current proposal seeks to provide a resolution pathway outside of protracted legal battles and potential future bankruptcy filings. Thousands of claims are currently pending against the company, stemming from allegations that its talc products led to serious health issues, including cancer. The company's talc litigation has been ongoing for an extended period, involving numerous plaintiffs and legal challenges.